secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENSAR, Inc. (LNSR)
CIK:        0001320350
Form:       8-K
Filed at:   2022-08-16T23:59:59+00:00
Accession:  0001564590-22-029547
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LENSAR announces first commercial ALLY System cases; Dr. Weinstock performs 15 surgeries
--------------------------------------------------------------------------------

- First commercial cases performed with ALLY System by Dr. Robert Weinstock at The Eye Institute of West Florida.
- Dr. Weinstock performed 15 laser-assisted cataract surgeries after installing his ALLY System.
- ALLY received FDA clearance in June 2022; company expects to install 8-12 systems in 2022 as controlled launch.
- First-generation LLS systems achieved 99.7% uptime; ALLY targets even higher service reliability.
- ALLY features Augmented Reality and Cataract Density Imaging for enhanced surgical guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320350/000156459022029547/0001564590-22-029547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320350/000156459022029547/lnsr-8k_20220816.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-029547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer